The Novel Antitumor Compound HCA Promotes Glioma Cell Death by Inducing Endoplasmic Reticulum Stress and Autophagy

Glioblastoma (GBM) is the most common and aggressive type of primary brain tumor in adults, and the median survival of patients with GBM is 14.5 months. Melitherapy is an innovative therapeutic approach to treat different diseases, including cancer, and it is based on the regulation of cell membrane...

Full description

Bibliographic Details
Main Authors: Roberto Beteta-Göbel, Javier Fernández-Díaz, Laura Arbona-González, Raquel Rodríguez-Lorca, Manuel Torres, Xavier Busquets, Paula Fernández-García, Pablo V. Escribá, Victoria Lladó
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
HCA
Online Access:https://www.mdpi.com/2072-6694/13/17/4290